Home › Schizophrenia › Connecticut
Schizophrenia clinical trials in Connecticut
9 studies for Schizophrenia are looking for participants at sites in Connecticut.
Cities in Connecticut
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0154, New Haven
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Nov 6, 2026 · NCT07424404Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0056, Hartford
- Local Institution - 0059, Hartford
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07379827A Study of Brenipatide in Adult Participants With Schizophrenia
- Institute of Living, Hartford
- Yale University School of Medicine, New Haven
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Oct 7, 2026 · NCT07410507Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
- West Haven Veterans Affairs Medical Center, West Haven
RecruitingPhase 1Healthy volunteers welcome
Ages 21 to 60 · All sexes · Updated Sep 2, 2026 · NCT06058702CLOZAPINE Response in Biotype-1
- Hartford Healthcare, Hartford
RecruitingPhase 4
Ages 18 to 60 · All sexes · Updated May 11, 2026 · NCT04580134Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
- Connecticut Mental Health Center, Clinical Neuroscience Research Unit, New Haven
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 55 · Men · Updated Apr 27, 2026 · NCT01730781Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- Hartford Hospital, Hartford
RecruitingObservational study
Ages 18 to 40 · All sexes · Updated Mar 10, 2026 · NCT06740383Social Isolation and Aging in Schizophrenia
- Olin Neuropsychiatry Research Center, Hartfort, Hartford
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 70 · All sexes · Updated Feb 19, 2026 · NCT07419321MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
- Yale School of Medicine, New Haven
RecruitingPhase 2/3
Ages 18 to 35 · All sexes · Updated Sep 25, 2025 · NCT06191965From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.